Cargando…

Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease associated with vascular inflammation and multisystem organ damage. The literature reporting EGPA incidence or prevalence is limited. We performed a systematic literature review and meta-analysis to describe the incidence, preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakes, Rupert W., Kwon, Namhee, Nordstrom, Beth, Goulding, Rebecca, Fahrbach, Kyle, Tarpey, Jialu, Van Dyke, Melissa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599408/
https://www.ncbi.nlm.nih.gov/pubmed/34159493
http://dx.doi.org/10.1007/s10067-021-05783-8
_version_ 1784600946889719808
author Jakes, Rupert W.
Kwon, Namhee
Nordstrom, Beth
Goulding, Rebecca
Fahrbach, Kyle
Tarpey, Jialu
Van Dyke, Melissa K.
author_facet Jakes, Rupert W.
Kwon, Namhee
Nordstrom, Beth
Goulding, Rebecca
Fahrbach, Kyle
Tarpey, Jialu
Van Dyke, Melissa K.
author_sort Jakes, Rupert W.
collection PubMed
description Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease associated with vascular inflammation and multisystem organ damage. The literature reporting EGPA incidence or prevalence is limited. We performed a systematic literature review and meta-analysis to describe the incidence, prevalence, and disease burden associated with EGPA. Real-world, observational, English-language studies in MEDLINE, MEDLINE In-Process, and Embase up to 6 June, 2019, were included. A single investigator screened all identified titles/abstracts and extracted data; an additional, independent investigator repeated the screening and validated the extracted data. A random-effects meta-analysis was conducted to generate pooled estimates for EGPA incidence and prevalence. Data from 100 eligible publications were extracted (32 with incidence/prevalence data, 65 with morbidity/healthcare resource data; 3 with both types of data). Significant evidence of between-study heterogeneity for reported incidence (p = 0.0013–0.0016) and prevalence (p = 0.0001–0.0006) estimates was observed. Global and European pooled estimates (95% confidence interval) of EGPA incidence were 1.22 (0.93, 1.60) and 1.07 (0.94, 1.35) cases per million person-years, respectively; global and European pooled estimates (95% confidence interval) for EGPA prevalence were 15.27 (11.89, 19.61) and 12.13 (6.98, 21.06) cases per million individuals, respectively. The proportions of patients experiencing relapses, or who had nasal polyps or severe asthma, varied considerably across studies. EGPA healthcare resource use was high, with inpatient admissions and emergency department visits reported for 17–42% and 25–42% of patients, respectively. Our results indicate that although global and European EGPA incidence and prevalence is low, the associated disease burden is substantial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10067-021-05783-8.
format Online
Article
Text
id pubmed-8599408
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85994082021-11-24 Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis Jakes, Rupert W. Kwon, Namhee Nordstrom, Beth Goulding, Rebecca Fahrbach, Kyle Tarpey, Jialu Van Dyke, Melissa K. Clin Rheumatol Review Article Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease associated with vascular inflammation and multisystem organ damage. The literature reporting EGPA incidence or prevalence is limited. We performed a systematic literature review and meta-analysis to describe the incidence, prevalence, and disease burden associated with EGPA. Real-world, observational, English-language studies in MEDLINE, MEDLINE In-Process, and Embase up to 6 June, 2019, were included. A single investigator screened all identified titles/abstracts and extracted data; an additional, independent investigator repeated the screening and validated the extracted data. A random-effects meta-analysis was conducted to generate pooled estimates for EGPA incidence and prevalence. Data from 100 eligible publications were extracted (32 with incidence/prevalence data, 65 with morbidity/healthcare resource data; 3 with both types of data). Significant evidence of between-study heterogeneity for reported incidence (p = 0.0013–0.0016) and prevalence (p = 0.0001–0.0006) estimates was observed. Global and European pooled estimates (95% confidence interval) of EGPA incidence were 1.22 (0.93, 1.60) and 1.07 (0.94, 1.35) cases per million person-years, respectively; global and European pooled estimates (95% confidence interval) for EGPA prevalence were 15.27 (11.89, 19.61) and 12.13 (6.98, 21.06) cases per million individuals, respectively. The proportions of patients experiencing relapses, or who had nasal polyps or severe asthma, varied considerably across studies. EGPA healthcare resource use was high, with inpatient admissions and emergency department visits reported for 17–42% and 25–42% of patients, respectively. Our results indicate that although global and European EGPA incidence and prevalence is low, the associated disease burden is substantial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10067-021-05783-8. Springer International Publishing 2021-06-23 2021 /pmc/articles/PMC8599408/ /pubmed/34159493 http://dx.doi.org/10.1007/s10067-021-05783-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Jakes, Rupert W.
Kwon, Namhee
Nordstrom, Beth
Goulding, Rebecca
Fahrbach, Kyle
Tarpey, Jialu
Van Dyke, Melissa K.
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
title Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
title_full Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
title_fullStr Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
title_full_unstemmed Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
title_short Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
title_sort burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599408/
https://www.ncbi.nlm.nih.gov/pubmed/34159493
http://dx.doi.org/10.1007/s10067-021-05783-8
work_keys_str_mv AT jakesrupertw burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis
AT kwonnamhee burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis
AT nordstrombeth burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis
AT gouldingrebecca burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis
AT fahrbachkyle burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis
AT tarpeyjialu burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis
AT vandykemelissak burdenofillnessassociatedwitheosinophilicgranulomatosiswithpolyangiitisasystematicliteraturereviewandmetaanalysis